| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, CD | 22 | 2016 | 4033 | 1.230 |
Why?
|
| GATA1 Transcription Factor | 3 | 2018 | 306 | 1.080 |
Why?
|
| Immunoenzyme Techniques | 48 | 2013 | 1697 | 1.080 |
Why?
|
| Bone Marrow | 21 | 2024 | 2926 | 1.060 |
Why?
|
| Hodgkin Disease | 29 | 2023 | 1384 | 1.060 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 28 | 2021 | 1433 | 1.040 |
Why?
|
| Leukemia, Monocytic, Acute | 2 | 2022 | 58 | 0.880 |
Why?
|
| Integrin alpha Chains | 2 | 2014 | 93 | 0.870 |
Why?
|
| Myeloproliferative Disorders | 10 | 2023 | 616 | 0.830 |
Why?
|
| Immunohistochemistry | 59 | 2021 | 11062 | 0.820 |
Why?
|
| Mesothelioma | 12 | 2014 | 774 | 0.800 |
Why?
|
| Lymphoma, B-Cell | 17 | 2023 | 945 | 0.790 |
Why?
|
| Hematologic Neoplasms | 4 | 2023 | 1925 | 0.780 |
Why?
|
| Dendritic Cells | 16 | 2023 | 2747 | 0.750 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 2 | 2017 | 49 | 0.730 |
Why?
|
| Leukemia, Hairy Cell | 5 | 2017 | 82 | 0.730 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2022 | 125 | 0.690 |
Why?
|
| Histiocytic Necrotizing Lymphadenitis | 3 | 2021 | 27 | 0.620 |
Why?
|
| Lymphoma, T-Cell | 5 | 2014 | 308 | 0.620 |
Why?
|
| Lymphoma, Non-Hodgkin | 19 | 2018 | 1374 | 0.600 |
Why?
|
| Leukemoid Reaction | 1 | 2018 | 18 | 0.600 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 2017 | 176 | 0.590 |
Why?
|
| Megakaryocytes | 3 | 2022 | 557 | 0.580 |
Why?
|
| Leukemia, Myeloid, Acute | 12 | 2023 | 3633 | 0.570 |
Why?
|
| Keratins | 21 | 2006 | 499 | 0.540 |
Why?
|
| Receptors, Transferrin | 2 | 2016 | 300 | 0.530 |
Why?
|
| Pleural Effusion, Malignant | 3 | 2014 | 108 | 0.530 |
Why?
|
| Molecular Chaperones | 2 | 2016 | 760 | 0.530 |
Why?
|
| Lymphoma | 28 | 2005 | 1899 | 0.530 |
Why?
|
| Histiocytosis, Langerhans-Cell | 5 | 2017 | 169 | 0.530 |
Why?
|
| Antibodies, Monoclonal | 26 | 2014 | 9244 | 0.520 |
Why?
|
| Lymph Nodes | 21 | 2024 | 3468 | 0.490 |
Why?
|
| Enteropathy-Associated T-Cell Lymphoma | 1 | 2014 | 13 | 0.480 |
Why?
|
| Plasma Cells | 9 | 2021 | 599 | 0.480 |
Why?
|
| Immunophenotyping | 23 | 2019 | 1867 | 0.480 |
Why?
|
| Adenocarcinoma | 17 | 2014 | 6359 | 0.470 |
Why?
|
| Leukemia, T-Cell | 1 | 2014 | 102 | 0.460 |
Why?
|
| T-Lymphocytes | 33 | 2024 | 10263 | 0.440 |
Why?
|
| B-Lymphocytes | 32 | 2024 | 4787 | 0.420 |
Why?
|
| Reed-Sternberg Cells | 8 | 2018 | 78 | 0.410 |
Why?
|
| Skin Neoplasms | 12 | 2023 | 5860 | 0.410 |
Why?
|
| Diagnosis, Differential | 34 | 2022 | 12985 | 0.410 |
Why?
|
| Lymphoproliferative Disorders | 8 | 2019 | 527 | 0.400 |
Why?
|
| Membrane Glycoproteins | 11 | 2009 | 3702 | 0.400 |
Why?
|
| Mediastinal Neoplasms | 8 | 2015 | 403 | 0.390 |
Why?
|
| WT1 Proteins | 2 | 2002 | 183 | 0.370 |
Why?
|
| Interferon Regulatory Factors | 2 | 2023 | 272 | 0.360 |
Why?
|
| Lymphoma, Mantle-Cell | 5 | 2019 | 238 | 0.360 |
Why?
|
| Lymphocytes | 14 | 2016 | 2606 | 0.350 |
Why?
|
| Neoplasm Proteins | 10 | 2015 | 3600 | 0.350 |
Why?
|
| Nuclear Proteins | 10 | 2023 | 5795 | 0.350 |
Why?
|
| Blood Proteins | 1 | 2016 | 1194 | 0.350 |
Why?
|
| Down Syndrome | 1 | 2018 | 916 | 0.330 |
Why?
|
| Glycoproteins | 7 | 2006 | 2201 | 0.320 |
Why?
|
| Lectins, C-Type | 4 | 2007 | 592 | 0.310 |
Why?
|
| Leukemia, Plasma Cell | 2 | 2019 | 46 | 0.300 |
Why?
|
| Antigens, Neoplasm | 13 | 2009 | 1998 | 0.290 |
Why?
|
| Polyps | 2 | 2004 | 200 | 0.290 |
Why?
|
| Gastrointestinal Neoplasms | 3 | 2014 | 957 | 0.280 |
Why?
|
| Humans | 264 | 2024 | 766812 | 0.280 |
Why?
|
| Receptors, Immunologic | 5 | 2012 | 1417 | 0.270 |
Why?
|
| Gene Rearrangement | 7 | 2012 | 1141 | 0.270 |
Why?
|
| Carrier Proteins | 10 | 2010 | 4926 | 0.270 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 2 | 2008 | 168 | 0.270 |
Why?
|
| Lymphoma, Follicular | 6 | 2012 | 460 | 0.270 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 2 | 2023 | 36 | 0.260 |
Why?
|
| Autopsy | 3 | 2024 | 1011 | 0.250 |
Why?
|
| Histiocytes | 10 | 2007 | 97 | 0.240 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 2 | 2024 | 273 | 0.240 |
Why?
|
| Paraffin Embedding | 4 | 2014 | 303 | 0.240 |
Why?
|
| Erythroid Cells | 2 | 2017 | 237 | 0.240 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2021 | 8623 | 0.240 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 7 | 2013 | 1642 | 0.230 |
Why?
|
| Microfilament Proteins | 5 | 2010 | 1130 | 0.220 |
Why?
|
| Biopsy | 19 | 2024 | 6779 | 0.220 |
Why?
|
| Antigens, Surface | 10 | 2007 | 1617 | 0.220 |
Why?
|
| Heart Neoplasms | 1 | 2007 | 374 | 0.220 |
Why?
|
| Plasmacytoma | 3 | 2021 | 171 | 0.220 |
Why?
|
| Translocation, Genetic | 9 | 2016 | 1392 | 0.220 |
Why?
|
| Histiocytosis | 2 | 2002 | 40 | 0.210 |
Why?
|
| SOXC Transcription Factors | 1 | 2023 | 41 | 0.210 |
Why?
|
| Endometrial Hyperplasia | 1 | 2004 | 102 | 0.210 |
Why?
|
| Killer Cells, Natural | 3 | 2019 | 2209 | 0.210 |
Why?
|
| Biopsy, Needle | 4 | 2014 | 1615 | 0.210 |
Why?
|
| Sarcoma, Myeloid | 1 | 2023 | 52 | 0.210 |
Why?
|
| Apolipoproteins | 4 | 2002 | 328 | 0.200 |
Why?
|
| Sensitivity and Specificity | 10 | 2018 | 14653 | 0.200 |
Why?
|
| Neoplasms, Plasma Cell | 2 | 2021 | 38 | 0.200 |
Why?
|
| beta 2-Microglobulin | 4 | 2018 | 330 | 0.200 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2019 | 582 | 0.200 |
Why?
|
| Histocytochemistry | 17 | 1987 | 697 | 0.200 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2004 | 415 | 0.190 |
Why?
|
| Female | 131 | 2024 | 396532 | 0.190 |
Why?
|
| Membrane Transport Proteins | 5 | 2002 | 1029 | 0.190 |
Why?
|
| Proteoglycans | 2 | 2005 | 806 | 0.190 |
Why?
|
| Protein-Tyrosine Kinases | 5 | 2020 | 2426 | 0.190 |
Why?
|
| Leukemia, Myeloid | 2 | 2006 | 694 | 0.190 |
Why?
|
| Langerhans Cells | 2 | 2017 | 169 | 0.190 |
Why?
|
| Lymphatic Diseases | 3 | 2009 | 318 | 0.180 |
Why?
|
| Autoimmune Lymphoproliferative Syndrome | 1 | 2020 | 13 | 0.180 |
Why?
|
| Kallikreins | 7 | 1983 | 219 | 0.180 |
Why?
|
| Sarcoma | 5 | 2022 | 1802 | 0.180 |
Why?
|
| Male | 112 | 2024 | 364154 | 0.170 |
Why?
|
| Spleen | 9 | 2012 | 2295 | 0.170 |
Why?
|
| Immunoglobulin kappa-Chains | 3 | 1999 | 171 | 0.170 |
Why?
|
| Middle Aged | 86 | 2024 | 223267 | 0.170 |
Why?
|
| Tryptases | 1 | 2020 | 175 | 0.170 |
Why?
|
| Mucin-1 | 7 | 2009 | 536 | 0.170 |
Why?
|
| Multiple Myeloma | 12 | 2021 | 5193 | 0.160 |
Why?
|
| Mutation | 16 | 2024 | 30214 | 0.160 |
Why?
|
| Cyclin D1 | 4 | 2017 | 453 | 0.160 |
Why?
|
| Colic | 1 | 2019 | 42 | 0.160 |
Why?
|
| Histological Techniques | 5 | 1991 | 193 | 0.160 |
Why?
|
| Waldenstrom Macroglobulinemia | 5 | 2019 | 1076 | 0.160 |
Why?
|
| Frozen Sections | 4 | 2014 | 153 | 0.160 |
Why?
|
| Blast Crisis | 2 | 2010 | 102 | 0.150 |
Why?
|
| Myeloid Cells | 3 | 2010 | 838 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2016 | 996 | 0.150 |
Why?
|
| Bone Marrow Cells | 7 | 2019 | 2413 | 0.150 |
Why?
|
| Mutation, Missense | 4 | 2020 | 2591 | 0.150 |
Why?
|
| Aged | 68 | 2024 | 171344 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2018 | 534 | 0.150 |
Why?
|
| Palatine Tonsil | 7 | 2001 | 193 | 0.150 |
Why?
|
| Actins | 3 | 2002 | 2061 | 0.150 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 2018 | 1442 | 0.150 |
Why?
|
| Neoplasm, Residual | 2 | 2021 | 1012 | 0.150 |
Why?
|
| Cell Transformation, Neoplastic | 8 | 2019 | 2841 | 0.140 |
Why?
|
| Neoplasms, Second Primary | 3 | 2019 | 1062 | 0.140 |
Why?
|
| Mastocytosis | 1 | 2020 | 150 | 0.140 |
Why?
|
| Neoplasm Metastasis | 6 | 2010 | 4892 | 0.140 |
Why?
|
| Adult | 86 | 2024 | 223305 | 0.140 |
Why?
|
| Peripheral Nerves | 1 | 2021 | 490 | 0.140 |
Why?
|
| Pleural Neoplasms | 3 | 2009 | 584 | 0.140 |
Why?
|
| Receptors, Progesterone | 1 | 2002 | 1159 | 0.140 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2016 | 1362 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2010 | 1117 | 0.140 |
Why?
|
| Anemia, Diamond-Blackfan | 1 | 2018 | 147 | 0.140 |
Why?
|
| Cation Transport Proteins | 3 | 2005 | 325 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-rel | 3 | 2005 | 71 | 0.140 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2018 | 329 | 0.140 |
Why?
|
| Gene Expression | 4 | 2019 | 7585 | 0.140 |
Why?
|
| GTP-Binding Proteins | 4 | 2009 | 946 | 0.130 |
Why?
|
| Antibodies, Neoplasm | 2 | 2009 | 282 | 0.130 |
Why?
|
| Transcription Factors | 7 | 2018 | 12159 | 0.130 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 2 | 2013 | 180 | 0.130 |
Why?
|
| Myositis, Inclusion Body | 3 | 2007 | 145 | 0.130 |
Why?
|
| Flow Cytometry | 12 | 2021 | 5890 | 0.130 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 2016 | 2510 | 0.130 |
Why?
|
| Carcinoembryonic Antigen | 5 | 1987 | 338 | 0.130 |
Why?
|
| Polymyositis | 2 | 2007 | 75 | 0.130 |
Why?
|
| Carcinoma | 8 | 2019 | 2325 | 0.130 |
Why?
|
| Histiocytosis, Sinus | 1 | 2016 | 45 | 0.130 |
Why?
|
| Testicular Neoplasms | 2 | 2015 | 806 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2020 | 723 | 0.130 |
Why?
|
| Umbilical Cord | 1 | 1997 | 179 | 0.130 |
Why?
|
| Skin | 7 | 2023 | 4499 | 0.130 |
Why?
|
| Chromosome Aberrations | 5 | 2016 | 1776 | 0.130 |
Why?
|
| Remission Induction | 5 | 2019 | 2413 | 0.130 |
Why?
|
| Granuloma, Plasma Cell | 3 | 2001 | 80 | 0.130 |
Why?
|
| Staining and Labeling | 9 | 1994 | 1075 | 0.120 |
Why?
|
| Fetal Death | 1 | 1997 | 434 | 0.120 |
Why?
|
| Cyclophilin A | 1 | 2015 | 57 | 0.120 |
Why?
|
| Microscopy, Electron | 12 | 2014 | 2551 | 0.120 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 1742 | 0.120 |
Why?
|
| Germinal Center | 1 | 1998 | 379 | 0.120 |
Why?
|
| Vincristine | 12 | 2008 | 1040 | 0.120 |
Why?
|
| Cyclophosphamide | 12 | 2018 | 2234 | 0.120 |
Why?
|
| Herpesvirus 4, Human | 4 | 2001 | 1080 | 0.120 |
Why?
|
| Cerebellar Neoplasms | 1 | 1999 | 588 | 0.120 |
Why?
|
| Ribosomes | 1 | 2018 | 496 | 0.120 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2009 | 1802 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 1992 | 370 | 0.120 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2016 | 330 | 0.120 |
Why?
|
| Muscle, Skeletal | 4 | 2021 | 4968 | 0.120 |
Why?
|
| Herpesvirus 8, Human | 4 | 2001 | 254 | 0.120 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2020 | 1403 | 0.110 |
Why?
|
| Skin Diseases | 3 | 2020 | 1084 | 0.110 |
Why?
|
| Indoles | 1 | 2002 | 1834 | 0.110 |
Why?
|
| Viral Matrix Proteins | 2 | 1998 | 193 | 0.110 |
Why?
|
| Mast Cells | 2 | 2020 | 1405 | 0.110 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 2 | 1992 | 281 | 0.110 |
Why?
|
| Receptors, Estrogen | 1 | 2002 | 2252 | 0.110 |
Why?
|
| Lymphocyte Activation | 5 | 2005 | 5502 | 0.110 |
Why?
|
| Colonic Polyps | 1 | 2019 | 557 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 2801 | 0.110 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 7 | 2019 | 318 | 0.110 |
Why?
|
| Breast Neoplasms | 11 | 2024 | 21162 | 0.110 |
Why?
|
| Lymphoma, Large-Cell, Immunoblastic | 2 | 2011 | 25 | 0.110 |
Why?
|
| Burkitt Lymphoma | 1 | 2016 | 338 | 0.110 |
Why?
|
| Epidermis | 4 | 1985 | 539 | 0.110 |
Why?
|
| Stromal Cells | 3 | 2006 | 1334 | 0.110 |
Why?
|
| Vasculitis | 2 | 1997 | 528 | 0.110 |
Why?
|
| Prognosis | 19 | 2023 | 29959 | 0.100 |
Why?
|
| Peroxidase | 2 | 1997 | 610 | 0.100 |
Why?
|
| Cell Proliferation | 5 | 2017 | 10451 | 0.100 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 3 | 2008 | 897 | 0.100 |
Why?
|
| Paraffin | 5 | 1991 | 36 | 0.100 |
Why?
|
| Receptors, IgE | 1 | 1994 | 375 | 0.100 |
Why?
|
| Karyotyping | 5 | 2007 | 1176 | 0.100 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2009 | 1105 | 0.100 |
Why?
|
| Antigens | 6 | 2002 | 1442 | 0.100 |
Why?
|
| Malaria, Cerebral | 1 | 2013 | 136 | 0.100 |
Why?
|
| Glomerulonephritis | 1 | 2014 | 333 | 0.100 |
Why?
|
| Neoplasms | 10 | 2022 | 22350 | 0.100 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1997 | 685 | 0.100 |
Why?
|
| Dendritic Cells, Follicular | 2 | 2009 | 50 | 0.100 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 1992 | 64 | 0.100 |
Why?
|
| MicroRNAs | 2 | 2021 | 3789 | 0.100 |
Why?
|
| Predictive Value of Tests | 5 | 2024 | 15425 | 0.100 |
Why?
|
| Aged, 80 and over | 22 | 2024 | 59548 | 0.100 |
Why?
|
| Fetal Proteins | 1 | 2012 | 100 | 0.100 |
Why?
|
| Cell Differentiation | 11 | 2017 | 11657 | 0.100 |
Why?
|
| Kidney Glomerulus | 1 | 2014 | 571 | 0.100 |
Why?
|
| Lectins | 3 | 1988 | 490 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1992 | 378 | 0.090 |
Why?
|
| Janus Kinase 2 | 2 | 2017 | 562 | 0.090 |
Why?
|
| Immunoglobulin J-Chains | 1 | 1991 | 26 | 0.090 |
Why?
|
| Neuroblastoma | 3 | 2009 | 1266 | 0.090 |
Why?
|
| Sarcoidosis | 2 | 2016 | 535 | 0.090 |
Why?
|
| Mice, SCID | 5 | 2020 | 2626 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2018 | 5022 | 0.090 |
Why?
|
| Cell Nucleus | 4 | 2017 | 2875 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2002 | 2329 | 0.090 |
Why?
|
| Mice, Inbred NOD | 4 | 2020 | 1836 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 2 | 2019 | 1203 | 0.090 |
Why?
|
| Adolescent | 29 | 2021 | 88902 | 0.090 |
Why?
|
| Receptors, Complement 3b | 3 | 2009 | 136 | 0.090 |
Why?
|
| Receptors, Complement 3d | 3 | 2009 | 117 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 7 | 2014 | 6066 | 0.090 |
Why?
|
| S100 Proteins | 2 | 2007 | 215 | 0.090 |
Why?
|
| Soft Tissue Neoplasms | 5 | 2007 | 1163 | 0.090 |
Why?
|
| Genetic Markers | 1 | 2017 | 2603 | 0.090 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2016 | 1131 | 0.090 |
Why?
|
| Antibody Specificity | 3 | 1990 | 1062 | 0.090 |
Why?
|
| Body Fluids | 2 | 2002 | 321 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1992 | 640 | 0.090 |
Why?
|
| Receptors, Antigen, B-Cell | 7 | 2004 | 546 | 0.090 |
Why?
|
| Immunochemistry | 8 | 1986 | 116 | 0.090 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 518 | 0.090 |
Why?
|
| Rabbits | 3 | 2013 | 4752 | 0.090 |
Why?
|
| Seminoma | 2 | 2009 | 136 | 0.080 |
Why?
|
| Hospitals | 1 | 2023 | 3885 | 0.080 |
Why?
|
| Antigens, Viral | 1 | 1994 | 995 | 0.080 |
Why?
|
| Cytodiagnosis | 1 | 2014 | 450 | 0.080 |
Why?
|
| Prednisone | 6 | 2008 | 1566 | 0.080 |
Why?
|
| Erythroid Precursor Cells | 1 | 2010 | 211 | 0.080 |
Why?
|
| Receptors, Chemokine | 2 | 2003 | 652 | 0.080 |
Why?
|
| Protein Precursors | 5 | 1985 | 1134 | 0.080 |
Why?
|
| Doxorubicin | 10 | 2008 | 2229 | 0.080 |
Why?
|
| Tumor Microenvironment | 2 | 2020 | 3942 | 0.080 |
Why?
|
| Synovial Membrane | 4 | 1995 | 536 | 0.080 |
Why?
|
| Leukemia | 5 | 1985 | 1521 | 0.080 |
Why?
|
| Cryoultramicrotomy | 1 | 2009 | 16 | 0.080 |
Why?
|
| Granuloma Annulare | 1 | 2009 | 28 | 0.080 |
Why?
|
| Pleural Effusion | 2 | 1996 | 344 | 0.080 |
Why?
|
| Ascitic Fluid | 2 | 2002 | 189 | 0.080 |
Why?
|
| Lung Neoplasms | 8 | 2008 | 13489 | 0.080 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2009 | 65 | 0.080 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2009 | 61 | 0.080 |
Why?
|
| Antigens, Differentiation | 1 | 2012 | 921 | 0.080 |
Why?
|
| Child | 19 | 2022 | 80670 | 0.080 |
Why?
|
| Epitopes | 3 | 1994 | 2526 | 0.080 |
Why?
|
| Headache | 1 | 2017 | 1260 | 0.080 |
Why?
|
| Silicone Elastomers | 1 | 1988 | 78 | 0.080 |
Why?
|
| Retrospective Studies | 19 | 2023 | 81657 | 0.080 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2009 | 186 | 0.080 |
Why?
|
| Ovarian Neoplasms | 3 | 2002 | 4903 | 0.080 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 1988 | 64 | 0.080 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1990 | 565 | 0.080 |
Why?
|
| Carboxylic Ester Hydrolases | 2 | 1997 | 99 | 0.080 |
Why?
|
| Clinical Enzyme Tests | 1 | 1988 | 114 | 0.080 |
Why?
|
| Transcription Factor AP-1 | 1 | 2010 | 321 | 0.080 |
Why?
|
| Clusterin | 2 | 2009 | 72 | 0.070 |
Why?
|
| Graft vs Host Disease | 2 | 2020 | 3079 | 0.070 |
Why?
|
| Hyperplasia | 4 | 2001 | 1150 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 1026 | 0.070 |
Why?
|
| Sperm Tail | 1 | 2007 | 15 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 1 | 2 | 2005 | 48 | 0.070 |
Why?
|
| Crohn Disease | 2 | 2019 | 2286 | 0.070 |
Why?
|
| Kartagener Syndrome | 1 | 2007 | 33 | 0.070 |
Why?
|
| Liver Neoplasms | 3 | 2002 | 4356 | 0.070 |
Why?
|
| Syndecans | 2 | 2005 | 75 | 0.070 |
Why?
|
| Rosette Formation | 4 | 1981 | 152 | 0.070 |
Why?
|
| Ribosomal Proteins | 2 | 2018 | 369 | 0.070 |
Why?
|
| Pancreas | 3 | 1983 | 1698 | 0.070 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 1988 | 177 | 0.070 |
Why?
|
| Dendritic Cell Sarcoma, Follicular | 1 | 2007 | 30 | 0.070 |
Why?
|
| Myosins | 2 | 1986 | 407 | 0.070 |
Why?
|
| Hematologic Diseases | 1 | 1991 | 502 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2010 | 1561 | 0.070 |
Why?
|
| Integrases | 1 | 2010 | 520 | 0.070 |
Why?
|
| Pericardial Effusion | 2 | 2002 | 246 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2012 | 1405 | 0.070 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2015 | 926 | 0.070 |
Why?
|
| Interferon-gamma | 2 | 2020 | 3157 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2005 | 3796 | 0.070 |
Why?
|
| Liver Diseases | 2 | 2010 | 1303 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2020 | 3360 | 0.070 |
Why?
|
| Mannose-Binding Lectins | 1 | 2007 | 100 | 0.070 |
Why?
|
| Histocompatibility Antigens | 2 | 1985 | 479 | 0.070 |
Why?
|
| Joint Prosthesis | 1 | 1988 | 251 | 0.070 |
Why?
|
| Syndecan-1 | 2 | 2005 | 163 | 0.070 |
Why?
|
| Estrogens | 3 | 1986 | 1528 | 0.070 |
Why?
|
| Interferon-beta | 2 | 2007 | 348 | 0.070 |
Why?
|
| Histiocytic Disorders, Malignant | 1 | 2006 | 14 | 0.070 |
Why?
|
| B-Lymphocyte Subsets | 3 | 2009 | 240 | 0.070 |
Why?
|
| Child, Preschool | 13 | 2021 | 42577 | 0.070 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 84 | 0.070 |
Why?
|
| Genetic Loci | 1 | 2015 | 2631 | 0.070 |
Why?
|
| Immunologic Surveillance | 1 | 2006 | 92 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2019 | 4215 | 0.070 |
Why?
|
| Genotype | 5 | 2019 | 13036 | 0.060 |
Why?
|
| Infant | 11 | 2020 | 36459 | 0.060 |
Why?
|
| Phenotype | 11 | 2009 | 16722 | 0.060 |
Why?
|
| Animals | 27 | 2021 | 168939 | 0.060 |
Why?
|
| Membrane Proteins | 4 | 2005 | 7869 | 0.060 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2005 | 29 | 0.060 |
Why?
|
| Amyloidosis | 3 | 2000 | 877 | 0.060 |
Why?
|
| Macrophages | 7 | 2013 | 5784 | 0.060 |
Why?
|
| Apolipoproteins D | 4 | 2002 | 14 | 0.060 |
Why?
|
| Mice | 17 | 2021 | 81898 | 0.060 |
Why?
|
| Sclerosis | 2 | 2024 | 211 | 0.060 |
Why?
|
| Interleukin-6 | 2 | 2014 | 3226 | 0.060 |
Why?
|
| Muscle, Smooth | 2 | 1986 | 930 | 0.060 |
Why?
|
| Clone Cells | 5 | 2021 | 1670 | 0.060 |
Why?
|
| Gene Expression Profiling | 7 | 2011 | 9528 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 3 | 2006 | 412 | 0.060 |
Why?
|
| Antigen Presentation | 3 | 2018 | 1250 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 4 | 2008 | 1621 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 2 | 2017 | 5536 | 0.060 |
Why?
|
| Trypsin | 1 | 1985 | 490 | 0.060 |
Why?
|
| Interferon-alpha | 2 | 2007 | 910 | 0.060 |
Why?
|
| Epithelium | 5 | 1987 | 1606 | 0.060 |
Why?
|
| Multiple Sclerosis | 1 | 2019 | 3229 | 0.060 |
Why?
|
| Lymphoid Tissue | 4 | 1997 | 445 | 0.060 |
Why?
|
| Intestinal Polyps | 2 | 2004 | 105 | 0.060 |
Why?
|
| Islets of Langerhans | 4 | 1983 | 1350 | 0.060 |
Why?
|
| Infectious Mononucleosis | 2 | 1998 | 133 | 0.060 |
Why?
|
| Iron | 2 | 2005 | 1812 | 0.060 |
Why?
|
| Androgens | 2 | 1986 | 1280 | 0.060 |
Why?
|
| Seizures | 1 | 2017 | 2996 | 0.060 |
Why?
|
| Hemochromatosis | 1 | 2005 | 175 | 0.060 |
Why?
|
| Breast Diseases | 2 | 2024 | 441 | 0.060 |
Why?
|
| Paraproteinemias | 2 | 2012 | 251 | 0.060 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2009 | 497 | 0.060 |
Why?
|
| Cholesteatoma | 1 | 1983 | 28 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 13 | 2008 | 11876 | 0.050 |
Why?
|
| Exons | 1 | 2009 | 2392 | 0.050 |
Why?
|
| Cilia | 1 | 2007 | 498 | 0.050 |
Why?
|
| Brain Neoplasms | 2 | 2019 | 9101 | 0.050 |
Why?
|
| Iron Overload | 1 | 2005 | 245 | 0.050 |
Why?
|
| Endometrium | 1 | 2006 | 406 | 0.050 |
Why?
|
| Endometrial Neoplasms | 1 | 1992 | 1381 | 0.050 |
Why?
|
| Kidney Transplantation | 3 | 2014 | 4278 | 0.050 |
Why?
|
| Pericardium | 1 | 2007 | 681 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 705 | 0.050 |
Why?
|
| Vaginal Smears | 1 | 2006 | 505 | 0.050 |
Why?
|
| Ear Neoplasms | 1 | 1983 | 118 | 0.050 |
Why?
|
| Hemoglobins | 3 | 2010 | 1531 | 0.050 |
Why?
|
| Crystallization | 2 | 2002 | 518 | 0.050 |
Why?
|
| Cell Count | 2 | 2004 | 1826 | 0.050 |
Why?
|
| Genes, Wilms Tumor | 1 | 2002 | 92 | 0.050 |
Why?
|
| Fibromatosis, Abdominal | 1 | 2001 | 21 | 0.050 |
Why?
|
| Formaldehyde | 3 | 1990 | 360 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5753 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2014 | 4424 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 18329 | 0.050 |
Why?
|
| Dermatomyositis | 1 | 2005 | 259 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 20146 | 0.050 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2002 | 425 | 0.050 |
Why?
|
| Cell Line, Tumor | 6 | 2019 | 17089 | 0.050 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1988 | 949 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2006 | 1073 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 1999 | 247 | 0.050 |
Why?
|
| Heart Atria | 1 | 2007 | 1362 | 0.050 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2002 | 161 | 0.050 |
Why?
|
| Splenic Diseases | 1 | 2001 | 91 | 0.050 |
Why?
|
| Myoglobin | 1 | 1981 | 158 | 0.050 |
Why?
|
| Lung | 3 | 2022 | 10068 | 0.050 |
Why?
|
| Immunoglobulin Heavy Chains | 4 | 2009 | 647 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2007 | 1132 | 0.050 |
Why?
|
| Ear, Middle | 1 | 1983 | 341 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2014 | 4504 | 0.050 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 3 | 2009 | 696 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2021 | 192 | 0.040 |
Why?
|
| Sarcoma, Kaposi | 1 | 2004 | 376 | 0.040 |
Why?
|
| Base Sequence | 5 | 2019 | 12415 | 0.040 |
Why?
|
| Paget Disease, Extramammary | 3 | 1985 | 50 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 1993 | 3114 | 0.040 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2002 | 210 | 0.040 |
Why?
|
| Inclusion Bodies | 1 | 2002 | 277 | 0.040 |
Why?
|
| Complementarity Determining Regions | 1 | 2021 | 154 | 0.040 |
Why?
|
| Herpesviridae Infections | 2 | 2001 | 268 | 0.040 |
Why?
|
| Tropomyosin | 1 | 2000 | 105 | 0.040 |
Why?
|
| Cell Movement | 4 | 2015 | 5204 | 0.040 |
Why?
|
| Immunoglobulins | 3 | 2005 | 853 | 0.040 |
Why?
|
| Naphthol AS D Esterase | 1 | 1979 | 14 | 0.040 |
Why?
|
| Apocrine Glands | 3 | 1985 | 31 | 0.040 |
Why?
|
| Sweat Glands | 3 | 1985 | 33 | 0.040 |
Why?
|
| Molecular Biology | 1 | 2023 | 573 | 0.040 |
Why?
|
| Cell Lineage | 4 | 2016 | 2573 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2001 | 4523 | 0.040 |
Why?
|
| Hamartoma | 2 | 1992 | 235 | 0.040 |
Why?
|
| Peanut Agglutinin | 3 | 1988 | 19 | 0.040 |
Why?
|
| Neoplasm Staging | 9 | 2016 | 11218 | 0.040 |
Why?
|
| Cytokines | 2 | 2011 | 7438 | 0.040 |
Why?
|
| Integrin beta3 | 1 | 1999 | 120 | 0.040 |
Why?
|
| Digestive System | 2 | 2019 | 244 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 2 | 2020 | 960 | 0.040 |
Why?
|
| Hepatocytes | 2 | 2005 | 1246 | 0.040 |
Why?
|
| Pseudolymphoma | 1 | 1999 | 30 | 0.040 |
Why?
|
| BRCA2 Protein | 1 | 2024 | 802 | 0.040 |
Why?
|
| Fixatives | 2 | 1991 | 90 | 0.040 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1999 | 282 | 0.040 |
Why?
|
| Cell Division | 5 | 1997 | 4473 | 0.040 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2022 | 496 | 0.040 |
Why?
|
| Joint Diseases | 1 | 1983 | 461 | 0.040 |
Why?
|
| Mycosis Fungoides | 3 | 1991 | 169 | 0.040 |
Why?
|
| Aminosalicylic Acids | 2 | 1976 | 37 | 0.040 |
Why?
|
| Lung Diseases | 2 | 2007 | 1940 | 0.040 |
Why?
|
| Pineal Gland | 1 | 1999 | 158 | 0.040 |
Why?
|
| Consanguinity | 1 | 2020 | 460 | 0.040 |
Why?
|
| Rhabdomyosarcoma | 1 | 1981 | 358 | 0.040 |
Why?
|
| Alleles | 2 | 2019 | 6896 | 0.040 |
Why?
|
| Chromosome Disorders | 1 | 2021 | 498 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2014 | 8065 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2014 | 2012 | 0.040 |
Why?
|
| Gene Frequency | 2 | 2019 | 3624 | 0.040 |
Why?
|
| DNA-Binding Proteins | 4 | 2007 | 9613 | 0.040 |
Why?
|
| Breast Implants | 1 | 2002 | 414 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 1981 | 610 | 0.040 |
Why?
|
| Recurrence | 3 | 2019 | 8507 | 0.040 |
Why?
|
| Multigene Family | 1 | 2021 | 1081 | 0.040 |
Why?
|
| Prostate | 1 | 1986 | 1760 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2020 | 2470 | 0.040 |
Why?
|
| Kidney | 4 | 2002 | 7073 | 0.040 |
Why?
|
| Tissue Distribution | 4 | 2007 | 2275 | 0.040 |
Why?
|
| Thymus Neoplasms | 1 | 2000 | 272 | 0.040 |
Why?
|
| Bone Marrow Examination | 1 | 2017 | 155 | 0.040 |
Why?
|
| Disease Progression | 4 | 2019 | 13642 | 0.040 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2001 | 343 | 0.040 |
Why?
|
| Muramidase | 1 | 1977 | 163 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2001 | 4050 | 0.040 |
Why?
|
| RNA Interference | 2 | 2018 | 2829 | 0.040 |
Why?
|
| BRCA1 Protein | 1 | 2024 | 1155 | 0.040 |
Why?
|
| Philadelphia Chromosome | 1 | 2017 | 119 | 0.040 |
Why?
|
| Adenofibroma | 2 | 1983 | 25 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2008 | 4570 | 0.040 |
Why?
|
| Cells, Cultured | 7 | 2018 | 18986 | 0.040 |
Why?
|
| Brain | 4 | 2019 | 27158 | 0.040 |
Why?
|
| Homeostasis | 2 | 2006 | 3343 | 0.030 |
Why?
|
| Reference Values | 2 | 1997 | 4914 | 0.030 |
Why?
|
| Clonal Anergy | 1 | 1997 | 169 | 0.030 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2004 | 2204 | 0.030 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 1979 | 287 | 0.030 |
Why?
|
| Calreticulin | 1 | 2017 | 115 | 0.030 |
Why?
|
| Isoniazid | 2 | 1976 | 279 | 0.030 |
Why?
|
| 5' Untranslated Regions | 1 | 2018 | 255 | 0.030 |
Why?
|
| Cytoplasm | 4 | 1982 | 1505 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2005 | 2493 | 0.030 |
Why?
|
| Enzyme Activation | 3 | 2008 | 3587 | 0.030 |
Why?
|
| Cohort Studies | 5 | 2023 | 41706 | 0.030 |
Why?
|
| Molecular Sequence Data | 6 | 2009 | 17609 | 0.030 |
Why?
|
| Granulocytes | 3 | 1996 | 551 | 0.030 |
Why?
|
| Tibia | 1 | 1982 | 1071 | 0.030 |
Why?
|
| Receptors, Mitogen | 2 | 1986 | 61 | 0.030 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2017 | 159 | 0.030 |
Why?
|
| Subrenal Capsule Assay | 1 | 2016 | 27 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2021 | 1384 | 0.030 |
Why?
|
| Algorithms | 1 | 2017 | 14073 | 0.030 |
Why?
|
| Renal Dialysis | 2 | 1998 | 1790 | 0.030 |
Why?
|
| Immunoglobulin M | 4 | 2012 | 1527 | 0.030 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 9546 | 0.030 |
Why?
|
| Breast | 2 | 2024 | 1972 | 0.030 |
Why?
|
| Mammography | 2 | 2024 | 2429 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 1999 | 680 | 0.030 |
Why?
|
| Cell Separation | 3 | 2010 | 1718 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 3 | 2016 | 4780 | 0.030 |
Why?
|
| Granuloma | 3 | 1988 | 329 | 0.030 |
Why?
|
| Erythrocytes | 4 | 2000 | 2412 | 0.030 |
Why?
|
| Encephalitis | 1 | 1999 | 441 | 0.030 |
Why?
|
| 17-Ketosteroids | 2 | 1974 | 36 | 0.030 |
Why?
|
| Nematoda | 1 | 1975 | 29 | 0.030 |
Why?
|
| Mastitis | 1 | 1975 | 41 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2019 | 3667 | 0.030 |
Why?
|
| Proteins | 2 | 2007 | 6002 | 0.030 |
Why?
|
| Immune Sera | 4 | 1983 | 605 | 0.030 |
Why?
|
| Survival Rate | 5 | 2012 | 12826 | 0.030 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 1975 | 64 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2007 | 3831 | 0.030 |
Why?
|
| Survival Analysis | 5 | 2019 | 10101 | 0.030 |
Why?
|
| Mesoderm | 3 | 1992 | 679 | 0.030 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 1997 | 429 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2003 | 2925 | 0.030 |
Why?
|
| Apoptosis | 3 | 2014 | 9514 | 0.030 |
Why?
|
| Review Literature as Topic | 1 | 2016 | 297 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2020 | 923 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1997 | 737 | 0.030 |
Why?
|
| Autoimmune Diseases | 2 | 2024 | 2255 | 0.030 |
Why?
|
| Duodenal Ulcer | 1 | 1994 | 117 | 0.030 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1997 | 663 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2016 | 369 | 0.030 |
Why?
|
| CD4-CD8 Ratio | 1 | 1993 | 114 | 0.030 |
Why?
|
| Dysgerminoma | 2 | 2009 | 66 | 0.030 |
Why?
|
| Mastectomy, Segmental | 1 | 2019 | 974 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2019 | 1788 | 0.030 |
Why?
|
| Cell Membrane | 4 | 2007 | 3642 | 0.030 |
Why?
|
| Monocytes | 4 | 2014 | 2599 | 0.030 |
Why?
|
| Cell Line | 4 | 2001 | 15564 | 0.030 |
Why?
|
| Turner Syndrome | 1 | 1974 | 129 | 0.030 |
Why?
|
| Methods | 5 | 1982 | 1065 | 0.030 |
Why?
|
| Young Adult | 4 | 2017 | 59939 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2007 | 1751 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2021 | 2669 | 0.030 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 1994 | 158 | 0.030 |
Why?
|
| In Situ Hybridization | 3 | 2004 | 1892 | 0.030 |
Why?
|
| Neprilysin | 2 | 2006 | 487 | 0.030 |
Why?
|
| Isoantigens | 1 | 1995 | 562 | 0.030 |
Why?
|
| Carcinoma, Transitional Cell | 3 | 1985 | 790 | 0.030 |
Why?
|
| Chromosome Banding | 1 | 1992 | 261 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2019 | 835 | 0.030 |
Why?
|
| Immunologic Techniques | 4 | 1989 | 212 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2018 | 1150 | 0.030 |
Why?
|
| Bone Neoplasms | 2 | 1982 | 2561 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 4539 | 0.030 |
Why?
|
| Sjogren's Syndrome | 2 | 1975 | 240 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2016 | 735 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 1997 | 1838 | 0.020 |
Why?
|
| Follow-Up Studies | 10 | 2014 | 39312 | 0.020 |
Why?
|
| Bleomycin | 6 | 1990 | 492 | 0.020 |
Why?
|
| alpha 1-Antichymotrypsin | 1 | 1991 | 18 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1994 | 590 | 0.020 |
Why?
|
| Chemokines, CC | 2 | 2003 | 285 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 545 | 0.020 |
Why?
|
| Duffy Blood-Group System | 1 | 2012 | 61 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 515 | 0.020 |
Why?
|
| Treatment Outcome | 6 | 2018 | 65286 | 0.020 |
Why?
|
| Down-Regulation | 2 | 2014 | 2931 | 0.020 |
Why?
|
| Toxoplasmosis | 2 | 1985 | 94 | 0.020 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 1976 | 836 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 2 | 2014 | 1349 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2010 | 1814 | 0.020 |
Why?
|
| Tritium | 4 | 1974 | 707 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2000 | 1893 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2020 | 1168 | 0.020 |
Why?
|
| Enterocytes | 2 | 2005 | 220 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 4114 | 0.020 |
Why?
|
| Signal Transduction | 4 | 2019 | 23618 | 0.020 |
Why?
|
| Lymphadenitis | 2 | 1985 | 99 | 0.020 |
Why?
|
| Methotrexate | 6 | 1990 | 1719 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 1997 | 1612 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2019 | 1536 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2006 | 286 | 0.020 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2006 | 594 | 0.020 |
Why?
|
| Leukemia, Lymphoid | 2 | 1981 | 307 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 3552 | 0.020 |
Why?
|
| HIV Infections | 1 | 1997 | 17532 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1991 | 774 | 0.020 |
Why?
|
| Mikulicz' Disease | 1 | 1970 | 8 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2014 | 1211 | 0.020 |
Why?
|
| Capillaries | 1 | 2013 | 755 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2744 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2012 | 630 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2024 | 18076 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2014 | 1088 | 0.020 |
Why?
|
| beta Catenin | 1 | 2015 | 1048 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 8540 | 0.020 |
Why?
|
| Perforin | 1 | 2010 | 167 | 0.020 |
Why?
|
| Blood Vessels | 2 | 2005 | 1111 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2008 | 5389 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2024 | 36570 | 0.020 |
Why?
|
| Sezary Syndrome | 2 | 1981 | 80 | 0.020 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2009 | 617 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 4 | 2001 | 6105 | 0.020 |
Why?
|
| Observer Variation | 1 | 2016 | 2614 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2011 | 740 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2014 | 1057 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2010 | 2456 | 0.020 |
Why?
|
| Epithelial Cells | 3 | 2007 | 3698 | 0.020 |
Why?
|
| Penicillinase | 1 | 1968 | 5 | 0.020 |
Why?
|
| Elbow | 1 | 2009 | 130 | 0.020 |
Why?
|
| Toe Joint | 1 | 1988 | 19 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 1996 | 1129 | 0.020 |
Why?
|
| RNA | 1 | 2019 | 2715 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2000 | 1057 | 0.020 |
Why?
|
| Penicillin Resistance | 1 | 1968 | 77 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 1110 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 3427 | 0.020 |
Why?
|
| DNA, Neoplasm | 3 | 2003 | 1741 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2000 | 13411 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 1970 | 381 | 0.020 |
Why?
|
| Menstruation | 2 | 2006 | 310 | 0.020 |
Why?
|
| Germinoma | 1 | 2009 | 132 | 0.020 |
Why?
|
| Groin | 1 | 1988 | 106 | 0.020 |
Why?
|
| Abdominal Neoplasms | 1 | 1990 | 286 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 2 | 1993 | 2730 | 0.020 |
Why?
|
| Bacteroides | 1 | 1968 | 165 | 0.020 |
Why?
|
| Aortitis | 1 | 1989 | 77 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2010 | 8310 | 0.020 |
Why?
|
| Diaphragm | 1 | 1990 | 357 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 1994 | 871 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2014 | 1902 | 0.020 |
Why?
|
| Ependyma | 1 | 2007 | 57 | 0.020 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2009 | 419 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1990 | 1622 | 0.020 |
Why?
|
| Dromaiidae | 1 | 2007 | 7 | 0.020 |
Why?
|
| Leucovorin | 5 | 1990 | 644 | 0.020 |
Why?
|
| Testosterone | 2 | 1975 | 2495 | 0.020 |
Why?
|
| Histiocytic Sarcoma | 1 | 2007 | 40 | 0.020 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2002 | 3186 | 0.020 |
Why?
|
| Immunoglobulin G | 4 | 1997 | 4559 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2535 | 0.020 |
Why?
|
| United States | 2 | 2014 | 72945 | 0.020 |
Why?
|
| Hypergammaglobulinemia | 1 | 2007 | 71 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 22351 | 0.020 |
Why?
|
| Phycoerythrin | 1 | 1986 | 9 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2002 | 2662 | 0.020 |
Why?
|
| Forearm | 1 | 2009 | 425 | 0.020 |
Why?
|
| Nephritis, Interstitial | 1 | 1988 | 157 | 0.020 |
Why?
|
| Deoxyribonucleases | 1 | 1988 | 209 | 0.020 |
Why?
|
| Cytogenetics | 2 | 2000 | 198 | 0.020 |
Why?
|
| Chemical Precipitation | 3 | 1971 | 174 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 3605 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2017 | 2979 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2007 | 294 | 0.020 |
Why?
|
| Tolonium Chloride | 1 | 1986 | 23 | 0.020 |
Why?
|
| Colonic Neoplasms | 3 | 1974 | 2535 | 0.020 |
Why?
|
| Androstane-3,17-diol | 1 | 1986 | 20 | 0.020 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2007 | 238 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 1997 | 511 | 0.020 |
Why?
|
| Adenoma, Islet Cell | 2 | 1983 | 72 | 0.020 |
Why?
|
| Erythema | 1 | 2008 | 261 | 0.020 |
Why?
|
| Splenic Neoplasms | 2 | 1985 | 97 | 0.020 |
Why?
|
| ROC Curve | 1 | 2014 | 3621 | 0.020 |
Why?
|
| Estradiol | 3 | 1986 | 1947 | 0.020 |
Why?
|
| Intestinal Mucosa | 3 | 2005 | 3041 | 0.020 |
Why?
|
| Patient Selection | 1 | 2018 | 4252 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2006 | 200 | 0.020 |
Why?
|
| Binding Sites | 2 | 1988 | 6013 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 3 | 1971 | 204 | 0.020 |
Why?
|
| Endocrine Glands | 1 | 2006 | 101 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2020 | 54872 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 3610 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1986 | 861 | 0.020 |
Why?
|
| Open Reading Frames | 2 | 2000 | 818 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 3408 | 0.020 |
Why?
|
| Dexamethasone | 6 | 1990 | 1962 | 0.020 |
Why?
|
| Pregnancy | 4 | 1997 | 30236 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2001 | 4168 | 0.020 |
Why?
|
| Androstenedione | 2 | 1975 | 138 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2005 | 316 | 0.020 |
Why?
|
| Fetal Diseases | 1 | 1970 | 915 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2009 | 4143 | 0.020 |
Why?
|
| Bone Transplantation | 2 | 1997 | 921 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2009 | 1639 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2012 | 9407 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1986 | 609 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2014 | 4277 | 0.010 |
Why?
|
| Antigens, CD1 | 1 | 2007 | 434 | 0.010 |
Why?
|
| Thyroid Gland | 1 | 1991 | 1170 | 0.010 |
Why?
|
| Viral Proteins | 2 | 1999 | 1801 | 0.010 |
Why?
|
| Respiratory System | 1 | 2007 | 562 | 0.010 |
Why?
|
| RNA, Messenger | 3 | 2005 | 12795 | 0.010 |
Why?
|
| Somatostatinoma | 1 | 1983 | 10 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 1994 | 2694 | 0.010 |
Why?
|
| Endoderm | 1 | 2005 | 165 | 0.010 |
Why?
|
| Sarcoma, Synovial | 1 | 1985 | 157 | 0.010 |
Why?
|
| Perineum | 1 | 1985 | 212 | 0.010 |
Why?
|
| Orchiectomy | 1 | 1986 | 466 | 0.010 |
Why?
|
| Carbon Radioisotopes | 2 | 1975 | 544 | 0.010 |
Why?
|
| Running | 1 | 1988 | 488 | 0.010 |
Why?
|
| Intestinal Absorption | 1 | 2005 | 400 | 0.010 |
Why?
|
| Tetracyclines | 1 | 2004 | 64 | 0.010 |
Why?
|
| GPI-Linked Proteins | 1 | 2005 | 472 | 0.010 |
Why?
|
| Medulloblastoma | 1 | 2009 | 679 | 0.010 |
Why?
|
| Goiter, Substernal | 1 | 1983 | 18 | 0.010 |
Why?
|
| Eosinophils | 2 | 1999 | 952 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 616 | 0.010 |
Why?
|
| Mucins | 1 | 1987 | 569 | 0.010 |
Why?
|
| Immunoglobulin A | 2 | 1997 | 992 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1986 | 574 | 0.010 |
Why?
|
| 17-Hydroxycorticosteroids | 2 | 1974 | 38 | 0.010 |
Why?
|
| Bone Diseases | 1 | 2007 | 412 | 0.010 |
Why?
|
| Antigens, CD20 | 2 | 1995 | 199 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2009 | 2659 | 0.010 |
Why?
|
| Methylation | 1 | 2006 | 1076 | 0.010 |
Why?
|
| Pigmentation Disorders | 1 | 2004 | 105 | 0.010 |
Why?
|
| Chemokine CCL22 | 1 | 2002 | 27 | 0.010 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2003 | 121 | 0.010 |
Why?
|
| Carcinoma, Small Cell | 1 | 1985 | 419 | 0.010 |
Why?
|
| Purpura | 1 | 2004 | 117 | 0.010 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 1983 | 121 | 0.010 |
Why?
|
| Chemokine CCL17 | 1 | 2002 | 26 | 0.010 |
Why?
|
| Chemokine CCL20 | 1 | 2003 | 64 | 0.010 |
Why?
|
| Rheumatoid Nodule | 2 | 1989 | 15 | 0.010 |
Why?
|
| Ampulla of Vater | 1 | 1983 | 150 | 0.010 |
Why?
|
| Receptors, CCR7 | 1 | 2003 | 105 | 0.010 |
Why?
|
| Salivary Glands | 2 | 1983 | 231 | 0.010 |
Why?
|
| Receptors, CCR6 | 1 | 2003 | 73 | 0.010 |
Why?
|
| Wound Healing | 1 | 1994 | 2800 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2007 | 1968 | 0.010 |
Why?
|
| Massachusetts | 1 | 2016 | 8890 | 0.010 |
Why?
|
| Receptors, CCR4 | 1 | 2002 | 77 | 0.010 |
Why?
|
| Fibrocystic Breast Disease | 1 | 1983 | 103 | 0.010 |
Why?
|
| DNA, Viral | 2 | 2000 | 2201 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 2815 | 0.010 |
Why?
|
| Anal Canal | 1 | 1985 | 375 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 2004 | 501 | 0.010 |
Why?
|
| Proinsulin | 2 | 1979 | 135 | 0.010 |
Why?
|
| Neuromuscular Diseases | 1 | 2005 | 260 | 0.010 |
Why?
|
| RNA Splicing | 1 | 2007 | 903 | 0.010 |
Why?
|
| Metaplasia | 1 | 1983 | 326 | 0.010 |
Why?
|
| Gold | 1 | 1986 | 482 | 0.010 |
Why?
|
| Neutrophils | 2 | 2010 | 3782 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2010 | 14473 | 0.010 |
Why?
|
| Colonic Diseases | 2 | 1974 | 204 | 0.010 |
Why?
|
| Silicone Gels | 1 | 2002 | 39 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 2003 | 340 | 0.010 |
Why?
|
| Carcinoid Tumor | 1 | 1983 | 225 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 2144 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 432 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1983 | 446 | 0.010 |
Why?
|
| Dermatitis | 1 | 2004 | 203 | 0.010 |
Why?
|
| Mucoproteins | 1 | 1981 | 49 | 0.010 |
Why?
|
| Pneumonia | 1 | 2013 | 2161 | 0.010 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2005 | 553 | 0.010 |
Why?
|
| Cattle | 2 | 1985 | 3815 | 0.010 |
Why?
|
| Salivary Gland Neoplasms | 1 | 1985 | 306 | 0.010 |
Why?
|
| Autoantigens | 1 | 2005 | 890 | 0.010 |
Why?
|
| Genes, bcl-2 | 1 | 2001 | 119 | 0.010 |
Why?
|
| Age of Onset | 1 | 2008 | 3343 | 0.010 |
Why?
|
| Genes, cdc | 1 | 2001 | 113 | 0.010 |
Why?
|
| Receptors, Complement | 1 | 1981 | 254 | 0.010 |
Why?
|
| Interleukin-13 | 1 | 2003 | 391 | 0.010 |
Why?
|
| Dogs | 1 | 1986 | 3834 | 0.010 |
Why?
|
| Lymphatic Metastasis | 3 | 1985 | 2901 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2012 | 26387 | 0.010 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 11924 | 0.010 |
Why?
|
| Estriol | 2 | 1970 | 53 | 0.010 |
Why?
|
| Centrifugation | 2 | 1971 | 121 | 0.010 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 2001 | 79 | 0.010 |
Why?
|
| Fluorometry | 2 | 1970 | 99 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 1751 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2001 | 190 | 0.010 |
Why?
|
| Chromosome Walking | 1 | 2000 | 26 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1981 | 526 | 0.010 |
Why?
|
| Thiamine | 1 | 2001 | 160 | 0.010 |
Why?
|
| Colorimetry | 2 | 1971 | 147 | 0.010 |
Why?
|
| Contig Mapping | 1 | 1999 | 56 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1999 | 113 | 0.010 |
Why?
|
| Factor VIII | 1 | 1982 | 349 | 0.010 |
Why?
|
| Yolk Sac | 1 | 2000 | 79 | 0.010 |
Why?
|
| Chemotaxis | 1 | 2003 | 598 | 0.010 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2004 | 617 | 0.010 |
Why?
|
| Pregnancy Complications | 2 | 1970 | 2971 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2001 | 861 | 0.010 |
Why?
|
| Sulfates | 2 | 1971 | 379 | 0.010 |
Why?
|
| Desmosomes | 1 | 1979 | 73 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 2001 | 527 | 0.010 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1999 | 40 | 0.010 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1982 | 289 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1981 | 2168 | 0.010 |
Why?
|
| Carboxypeptidases | 1 | 1979 | 121 | 0.010 |
Why?
|
| Genome, Human | 1 | 2012 | 4443 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 6853 | 0.010 |
Why?
|
| Cyclin D | 1 | 1999 | 71 | 0.010 |
Why?
|
| Actuarial Analysis | 2 | 1993 | 370 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 1675 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1992 | 5990 | 0.010 |
Why?
|
| Complement System Proteins | 2 | 1979 | 738 | 0.010 |
Why?
|
| Cervix Uteri | 1 | 1982 | 575 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2001 | 1767 | 0.010 |
Why?
|
| Communicable Diseases | 1 | 2007 | 872 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 5330 | 0.010 |
Why?
|
| Diverticulitis, Colonic | 3 | 1974 | 140 | 0.010 |
Why?
|
| Pneumothorax | 1 | 1982 | 393 | 0.010 |
Why?
|
| Immunity | 1 | 2004 | 1002 | 0.010 |
Why?
|
| Keratinocytes | 1 | 2003 | 876 | 0.010 |
Why?
|
| Cardiac Tamponade | 1 | 1979 | 175 | 0.010 |
Why?
|
| Teratoma | 1 | 1981 | 405 | 0.010 |
Why?
|
| Receptors, Fc | 1 | 1981 | 537 | 0.010 |
Why?
|
| Pericarditis | 1 | 1979 | 136 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 2 | 1995 | 3788 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 6514 | 0.010 |
Why?
|
| Xenopus | 1 | 2000 | 710 | 0.010 |
Why?
|
| Esterases | 1 | 1977 | 89 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2000 | 748 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2004 | 2721 | 0.010 |
Why?
|
| Papillomaviridae | 1 | 1984 | 1139 | 0.010 |
Why?
|
| Shoulder | 1 | 1979 | 300 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2003 | 1144 | 0.010 |
Why?
|
| Swine | 2 | 1985 | 5985 | 0.010 |
Why?
|
| Confusion | 1 | 1999 | 278 | 0.010 |
Why?
|
| Antibodies, Heterophile | 1 | 1997 | 128 | 0.010 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1998 | 342 | 0.010 |
Why?
|
| Introns | 1 | 1999 | 966 | 0.010 |
Why?
|
| Erythropoiesis | 1 | 1981 | 692 | 0.010 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1997 | 139 | 0.010 |
Why?
|
| Vagina | 1 | 1982 | 849 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2000 | 1989 | 0.010 |
Why?
|
| Transplantation, Homologous | 3 | 1993 | 4860 | 0.010 |
Why?
|
| Caspases | 1 | 1999 | 881 | 0.010 |
Why?
|
| Cyclins | 1 | 1999 | 605 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2001 | 1716 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2000 | 910 | 0.010 |
Why?
|
| Muscles | 1 | 1981 | 1576 | 0.010 |
Why?
|
| Intestines | 1 | 2005 | 1904 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2004 | 1728 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 2007 | 2101 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2009 | 8728 | 0.010 |
Why?
|
| Acute Disease | 1 | 2006 | 7240 | 0.010 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1977 | 289 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1971 | 2478 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 1988 | 1946 | 0.010 |
Why?
|
| Virus Latency | 1 | 1998 | 359 | 0.010 |
Why?
|
| Salvage Therapy | 2 | 1993 | 1274 | 0.010 |
Why?
|
| Time Factors | 6 | 1998 | 40149 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1979 | 855 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1996 | 220 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 2746 | 0.010 |
Why?
|
| Adenoma | 2 | 1983 | 2155 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1995 | 341 | 0.010 |
Why?
|
| Chromatography, Paper | 1 | 1974 | 76 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 1998 | 602 | 0.010 |
Why?
|
| Leydig Cells | 1 | 1974 | 55 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 1984 | 1424 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 1975 | 194 | 0.010 |
Why?
|
| Cecum | 1 | 1975 | 231 | 0.010 |
Why?
|
| Organoids | 1 | 1980 | 740 | 0.010 |
Why?
|
| Immunoglobulin lambda-Chains | 2 | 1984 | 84 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1979 | 1266 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2003 | 2856 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 5795 | 0.010 |
Why?
|
| Gonadotropins | 1 | 1974 | 241 | 0.010 |
Why?
|
| Lip | 1 | 1975 | 196 | 0.010 |
Why?
|
| Rectal Diseases | 1 | 1974 | 141 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2001 | 4618 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 7612 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1998 | 2921 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2001 | 1885 | 0.010 |
Why?
|
| Intestinal Perforation | 1 | 1974 | 254 | 0.010 |
Why?
|
| Fiber Optic Technology | 1 | 1974 | 290 | 0.010 |
Why?
|
| Canada | 2 | 1976 | 2126 | 0.010 |
Why?
|
| Lymphopenia | 1 | 1995 | 300 | 0.010 |
Why?
|
| Inflammation | 2 | 2007 | 10863 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 4401 | 0.010 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2000 | 1608 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1989 | 8928 | 0.010 |
Why?
|
| Fishes | 1 | 1975 | 607 | 0.010 |
Why?
|
| Knee Prosthesis | 1 | 1995 | 395 | 0.010 |
Why?
|
| Antigens, CD19 | 1 | 1995 | 444 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 1981 | 2060 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 1985 | 2355 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1984 | 2039 | 0.010 |
Why?
|
| Sulfuric Acids | 1 | 1971 | 36 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1992 | 432 | 0.010 |
Why?
|
| Drug Therapy, Combination | 3 | 1976 | 6306 | 0.010 |
Why?
|
| Goiter | 1 | 1991 | 86 | 0.010 |
Why?
|
| Anencephaly | 1 | 1970 | 20 | 0.010 |
Why?
|
| Metaphase | 1 | 1991 | 143 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 22248 | 0.010 |
Why?
|
| Placenta | 1 | 2000 | 1726 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 1990 | 10745 | 0.010 |
Why?
|
| Erythroblastosis, Fetal | 1 | 1970 | 62 | 0.010 |
Why?
|
| Vimentin | 1 | 1991 | 257 | 0.010 |
Why?
|
| RNA, Viral | 1 | 1998 | 2867 | 0.010 |
Why?
|
| Dehydroepiandrosterone | 1 | 1971 | 249 | 0.010 |
Why?
|
| Trisomy | 1 | 1991 | 260 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2001 | 3610 | 0.010 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 1984 | 391 | 0.010 |
Why?
|
| Splenomegaly | 1 | 1990 | 191 | 0.010 |
Why?
|
| Lymphography | 1 | 1990 | 189 | 0.010 |
Why?
|
| Cytological Techniques | 1 | 1991 | 217 | 0.000 |
Why?
|
| Oxacillin | 1 | 1968 | 41 | 0.000 |
Why?
|
| Intestine, Small | 1 | 1975 | 1217 | 0.000 |
Why?
|
| Transplantation, Heterologous | 1 | 1997 | 2391 | 0.000 |
Why?
|
| Penicillin G | 1 | 1968 | 40 | 0.000 |
Why?
|
| Pregnancy in Diabetics | 1 | 1970 | 198 | 0.000 |
Why?
|
| Chromatography, Thin Layer | 1 | 1968 | 211 | 0.000 |
Why?
|
| Cell Adhesion | 1 | 1995 | 3093 | 0.000 |
Why?
|
| Drug Administration Schedule | 2 | 1987 | 4853 | 0.000 |
Why?
|
| Ampicillin | 1 | 1968 | 138 | 0.000 |
Why?
|
| Zebrafish | 1 | 2000 | 3035 | 0.000 |
Why?
|
| Transplantation, Autologous | 1 | 1993 | 2127 | 0.000 |
Why?
|
| Cytomegalovirus Infections | 1 | 1974 | 838 | 0.000 |
Why?
|
| Aging | 1 | 2007 | 8728 | 0.000 |
Why?
|
| Laparotomy | 1 | 1990 | 459 | 0.000 |
Why?
|
| Colon | 1 | 1974 | 1797 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1998 | 9661 | 0.000 |
Why?
|
| Radiotherapy Dosage | 1 | 1993 | 2916 | 0.000 |
Why?
|
| Aorta, Abdominal | 1 | 1989 | 627 | 0.000 |
Why?
|
| Risk Factors | 2 | 2006 | 74889 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1994 | 4019 | 0.000 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1997 | 4349 | 0.000 |
Why?
|
| Shoulder Joint | 1 | 1992 | 745 | 0.000 |
Why?
|
| Central Nervous System Diseases | 1 | 1990 | 518 | 0.000 |
Why?
|
| Exocrine Glands | 1 | 1985 | 46 | 0.000 |
Why?
|
| Socioeconomic Factors | 1 | 1998 | 7841 | 0.000 |
Why?
|
| Probability | 1 | 1990 | 2476 | 0.000 |
Why?
|
| Endoscopy | 1 | 1974 | 1854 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1994 | 6507 | 0.000 |
Why?
|
| Myometrium | 1 | 1985 | 174 | 0.000 |
Why?
|
| Postoperative Complications | 2 | 1999 | 15831 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1970 | 1441 | 0.000 |
Why?
|
| Thyroid Nodule | 1 | 1991 | 765 | 0.000 |
Why?
|
| Risk | 1 | 1976 | 9602 | 0.000 |
Why?
|
| Viral Structural Proteins | 1 | 1984 | 93 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1994 | 8108 | 0.000 |
Why?
|
| Aorta, Thoracic | 1 | 1989 | 1110 | 0.000 |
Why?
|
| Gynecomastia | 1 | 1983 | 88 | 0.000 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1995 | 4410 | 0.000 |
Why?
|
| Age Factors | 2 | 1990 | 18397 | 0.000 |
Why?
|
| Uromodulin | 1 | 1981 | 49 | 0.000 |
Why?
|
| Urinary Tract | 1 | 1985 | 305 | 0.000 |
Why?
|
| Vulvar Neoplasms | 1 | 1984 | 266 | 0.000 |
Why?
|
| Axilla | 1 | 1984 | 622 | 0.000 |
Why?
|
| Tumor Virus Infections | 1 | 1984 | 438 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 3 | 1991 | 20710 | 0.000 |
Why?
|
| Lacrimal Apparatus | 1 | 1983 | 224 | 0.000 |
Why?
|
| Immunodiffusion | 1 | 1979 | 141 | 0.000 |
Why?
|
| Carcinoma, Papillary | 1 | 1985 | 791 | 0.000 |
Why?
|
| Leukocyte Count | 1 | 1983 | 1606 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 1982 | 11094 | 0.000 |
Why?
|
| Thyroidectomy | 1 | 1985 | 912 | 0.000 |
Why?
|
| Glucose | 1 | 1970 | 4340 | 0.000 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1985 | 1494 | 0.000 |
Why?
|
| Carcinoma in Situ | 1 | 1984 | 784 | 0.000 |
Why?
|
| Clinical Trials as Topic | 2 | 1990 | 8045 | 0.000 |
Why?
|
| Rats | 1 | 1994 | 23717 | 0.000 |
Why?
|
| Pain | 1 | 1992 | 5098 | 0.000 |
Why?
|
| Diet | 1 | 1975 | 8088 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1979 | 1729 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1986 | 6329 | 0.000 |
Why?
|
| Immune Adherence Reaction | 1 | 1976 | 29 | 0.000 |
Why?
|
| Binding Sites, Antibody | 1 | 1975 | 340 | 0.000 |
Why?
|
| Species Specificity | 1 | 1979 | 2413 | 0.000 |
Why?
|
| Parotid Gland | 1 | 1975 | 178 | 0.000 |
Why?
|
| Nitrogen Mustard Compounds | 1 | 1974 | 44 | 0.000 |
Why?
|
| Procarbazine | 1 | 1974 | 172 | 0.000 |
Why?
|
| Remission, Spontaneous | 1 | 1974 | 384 | 0.000 |
Why?
|
| Meningeal Neoplasms | 1 | 1983 | 1255 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1974 | 642 | 0.000 |
Why?
|
| Sheep | 1 | 1975 | 1448 | 0.000 |
Why?
|
| Antibodies | 1 | 1979 | 2421 | 0.000 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1974 | 1126 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1979 | 5143 | 0.000 |
Why?
|
| Drug Resistance, Microbial | 1 | 1969 | 832 | 0.000 |
Why?
|
| Colitis | 1 | 1974 | 1238 | 0.000 |
Why?
|
| Radiography | 1 | 1976 | 6968 | 0.000 |
Why?
|
| Rectal Neoplasms | 1 | 1974 | 1183 | 0.000 |
Why?
|
| Insulin | 1 | 1979 | 6608 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1979 | 3446 | 0.000 |
Why?
|
| Colitis, Ulcerative | 1 | 1974 | 1920 | 0.000 |
Why?
|
| Palliative Care | 1 | 1974 | 3640 | 0.000 |
Why?
|